B. Riley initiates Foghorn Therapeutics at buy with $10 price target, citing promising development of SMARCA2 inhibitors for ...
Discover why ARM's growth prospects in data centers, CPUs, smartphones, and automotive tech are promising, despite its high ...
Whether you like or dislike her politics, one thing former House Speaker and current Rep. Nancy Pelosi has proven to be is a ...